EX1.AX
Price:
$0.011
Market Cap:
$1.93M
Exopharm Limited, a clinical-stage company, develops transformative medicines based upon extracellular vesicles (EVs) in Australia. The company's technology includes extracellular vesicle positioning system that allows specific molecules to be attached to the surface of exosomes to guide them to target tissues or cell types; leveraging oligonucleotide packing for amplified dosing, which enables specific RNA molecules to be preferentially loaded into exosomes as a therapeutic cargo; ligand-based exosome affinity purification that isolates and purifies exosomes from biofluids like blood and cell culture media. Its engineered EVs products comprise Fortrexo CoV for the treatment of SARS-CoV-2 in...[Read more]
Industry
Biotechnology
IPO Date
2018-12-17
Stock Exchange
ASX
Ticker
EX1.AX
According to Exopharm Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 1.82M. This represents a change of -42.07% compared to the average of 3.15M of the last 4 quarters.
The mean historical Enterprise Value of Exopharm Limited over the last ten years is 30.79M. The current 1.82M Enterprise Value has changed 492.48% with respect to the historical average. Over the past ten years (40 quarters), EX1.AX's Enterprise Value was at its highest in in the June 2021 quarter at 88.08M. The Enterprise Value was at its lowest in in the December 2023 quarter at -674023.51.
Average
30.79M
Median
25.74M
Minimum
52.00K
Maximum
71.31M
Discovering the peaks and valleys of Exopharm Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 90.90%
Maximum Annual Enterprise Value = 71.31M
Minimum Annual Increase = -93.34%
Minimum Annual Enterprise Value = 52.00K
| Year | Enterprise Value | Change |
|---|---|---|
| 2023 | 1.47M | -93.34% |
| 2022 | 22.00M | -69.15% |
| 2021 | 71.31M | 177.07% |
| 2020 | 25.74M | 21.26% |
| 2019 | 21.22M | -47.82% |
| 2018 | 40.67M | -14.05% |
| 2017 | 47.32M | 0% |
| 2016 | 47.32M | 90.90% |
The current Enterprise Value of Exopharm Limited (EX1.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
31.59M
5-year avg
28.35M
10-year avg
30.79M
Exopharm Limited’s Enterprise Value is greater than Hexima Limited (530.28K), greater than Wellfully Limited (1.52M), less than The Sustainable Nutrition Group Ltd (2.21M), less than Health House International Limited (0), less than Regeneus Ltd (5.32M), less than Jayex Technology Limited (3.81M), less than Uscom Limited (4.42M), greater than Total Brain Limited (767.67K), less than Allegra Medical Technologies Limited (6.59M), greater than Medibio Limited (239.48K),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 530.28K | $2.17M | |
| 1.52M | $1.48M | |
| 2.21M | $1.41M | |
| 0 | $891.13K | |
| 5.32M | $3.68M | |
| 3.81M | $281.28K | |
| 4.42M | $3.12M | |
| 767.67K | $267.44K | |
| 6.59M | $3.47M | |
| 239.48K | $4.55M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exopharm Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Exopharm Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Exopharm Limited's Enterprise Value?
What is the highest Enterprise Value for Exopharm Limited (EX1.AX)?
What is the 3-year average Enterprise Value for Exopharm Limited (EX1.AX)?
What is the 5-year average Enterprise Value for Exopharm Limited (EX1.AX)?
How does the current Enterprise Value for Exopharm Limited (EX1.AX) compare to its historical average?